The PIM kinase inhibitor TP-3654 demonstrates efficacy in a murine model of myelofibrosis

被引：2

作者：

Dutta, Avik ^{[1
]}

Nath, Dipmoy ^{[1
]}

Yang, Yue ^{[1
]}

Mohi, Golam ^{[1
]}

机构：

[1] Univ Virginia, Charlottesville, VA USA

来源：

CANCER RESEARCH | 2018年 / 78卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2018-1874

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1874

引用

页数：2

共 50 条

[41] Impact of TP53 Mutations on EGFR-Tyrosine Kinase Inhibitor Efficacy and Potential Treatment Strategy
Fu, Jing
Tong, Yuyang
Xu, Ziguang
Li, Yaonan
Zhao, Ya
Wang, Tao
Li, Cuidan
Cang, Shundong
CLINICAL LUNG CANCER, 2023, 24 (01) : 29 - 39
[42] Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor-naive patients with myelofibrosis: Results of a phase II trial
Zhang, Yi
Zhou, Hu
Jiang, Zhongxing
Wu, Dengshu
Zhuang, Junling
Li, Wei
Jiang, Qian
Wang, Xiuli
Huang, Jinwen
Zhu, Huanling
Yang, Linhua
Du, Xin
Li, Fei
Xia, Ruixiang
Zhang, Feng
Hu, Jianda
Li, Yan
Hu, Yu
Liu, Jing
Jin, Chenghao
Sun, Kai
Zhou, Zeping
Wu, Liqing
Yu, Wenjuan
Jin, Jie
AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (12) : 1510 - 1519
[43] Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in Moloney murine leukemia virus (PIM-1) kinase
Bullock, AN
Debreczeni, JÉ
Fedorov, OY
Nelson, A
Marsden, BD
Knapp, S
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (24) : 7604 - 7614
[44] Efficacy of a Novel Tricyclic Topoisomerase Inhibitor in a Murine Model of Neisseria gonorrhoeae Infection
Savage, Victoria J.
Charrier, Cedric
Salisbury, Anne-Marie
Box, Helen
Chaffer-Malam, Nathan
Huxley, Anthony
Kirk, Ralph
Noonan, Gary M.
Mohmed, Sarfraz
Craighead, Mark W.
Ratcliffe, Andrew J.
Best, Stuart A.
Stokes, Neil R.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (09) : 5592 - 5594
[45] The Novel Kinase Inhibitor PRT062070 (Cerdulatinib) Demonstrates Efficacy in Models of Autoimmunity and B-Cell Cancer
Coffey, Greg
Betz, Andreas
DeGuzman, Francis
Pak, Yvonne
Inagaki, Mayuko
Baker, Dale C.
Hollenbach, Stanley J.
Pandey, Anjali
Sinha, Uma
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 351 (03): : 538 - 548
[46] Gb002, A Novel Inhaled Pdgfr Kinase Inhibitor, Demonstrates Efficacy in the Su5416 Hypoxia Rat Model of Pulmonary Arterial Hypertension (pah)
Galkin, Anna
Clemons, Bryan
Garcia, Eduardo
Brooks, Jennifer
Slee, Debbie
Salter-Cid, Luisa
Zisman, Larry
CIRCULATION, 2019, 140
[47] Effects of a Janus kinase inhibitor, pyridone 6, on airway responses in a murine model of asthma
Matsunaga, Yuko
Inoue, Hiromasa
Fukuyama, Satoru
Yoshida, Hideyuki
Moriwaki, Atsushi
Matsumoto, Takafumi
Matsumoto, Koichiro
Asai, Yukari
Kubo, Masato
Yoshimura, Akihiko
Nakanishi, Yoichi
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 404 (01) : 261 - 267
[48] Phosphoinositide 3-kinase-δ inhibitor reduces vascular permeability in a murine model of asthma
Lee, Kyung Sun
Park, Seoung Ju
Kim, So Ri
Min, Kyung Hoon
Jin, Sun Mi
Puri, Kamal D.
Lee, Yong Chul
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (02) : 403 - 409
[49] Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model
Cao, Mengde
Xu, Yiling
Youn, Je-in
Cabrera, Roniel
Zhang, Xiaokui
Gabrilovich, Dmitry
Nelson, David R.
Liu, Chen
LABORATORY INVESTIGATION, 2011, 91 (04) : 598 - 608
[50] A novel JAK inhibitor, peficitinib, demonstrates potent efficacy in a rat adjuvant-induced arthritis model
Ito, Misato
Yamazaki, Shunji
Yamagami, Kaoru
Kuno, Masako
Morita, Yoshiaki
Okuma, Kenji
Nakamura, Koji
Chida, Noboru
Inami, Masamichi
Inoue, Takayuki
Shirakami, Shohei
Higashi, Yasuyuki
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (01) : 25 - 33

← 1 2 3 4 5 →